Table 1.
The bioactivities and sources of BCDO indole alkaloids.
| Compound | Source | Bioactivity |
|---|---|---|
| Diketopiperazines | ||
|
P. brevicompactum2,7,9,30,103,153–163 P. viridicatum10,158,164–167 P. ochraceum11 P. duclauxii168 Penicillium sp.169 |
Insecticidal activity129,130 |
|
Chemical synthesis26,31 | |
|
P. brevicompactum
2,7,9,30,159,166
P. viridicatum 10 |
|
|
Chemical synthesis22,23,26,31 | |
|
P. brevicompactum 7,9,103,160,166 | Cytotoxic activity (IC50, 15.6 μM against HCT116 cell line)103 |
|
P. brevicompactum 7,9 | Insecticidal activity129 |
|
Chemical synthesis7,159 | |
|
P. brevicompactum 2,103 | |
|
P. brevicompactum 2,103 | |
|
P. brevicompactum 2 | |
|
P. brevicompactum 2 | |
|
P. brevicompactum 2 | |
|
Aspergillus sp.170 Annulohypoxylon cf. stygium171 A. protuberus34 A. versicolor63 |
Cytotoxic activity (IC50, 27 and 29 μM against HeLa and L1210 cell lines, respectively)34 Inhibition of RANKL-induced osteoclastogenic differentiation133 |
|
A. amoenus 133,172 | |
|
A. sulphureus and Isaria felina co-culture132 Fusarium sambucinum134 A. ochraceus131,173 Aspergillus sp.131,174 A. cf. stygium171 A. protuberus34 A. versicolor63 |
Anticancer activity (~64% inhibition ratio of the colony formation of 22Rv1 prostate cancer cells at 100 μM)132 Anti-inflammatory activity (36.8% and 40.6% inhibition ratios of cytokines IL-1β and TNF-α at the concentration of 20 μM, respectively)131 Cytotoxic activity (IC50, 52 and 36 μM against HeLa and L1210 cell lines, respectively)34 Inhibition of RANKL-induced osteoclastogenic differentiation133 |
|
A. taichungensis
64
A. amoenus 36,172 |
|
|
A. amoenus 172 | |
|
A. sulphureus and I. felina co-culture132 Aspergillus sp.35,170,174 A. ochraceus135 A. ostianus135 A. versicolor135 |
|
|
A. taichungensis 64 | |
|
Aspergillus sp.35 A. ochraceus135 |
Antitumor (IC50, 244, 87, 219, and 279 nM against SMMC-7721, HCT-8, MCF-7, and HUVEC cell lines, respectively; IC50, 0.66–2.70 μM against various liver cancer cell lines)135 |
|
Photoinduced product175 | |
|
Aspergillus sp.35,136 | Antifungal activity (MIC, 25 μg/mL against R. solani)136 Anti-inflammatory activity (IC50, 46.2 μM against P. acnes-induced THP-1 cells)136 |
|
A. amoenus 172 | |
|
Aspergillus sp.35 A. ochraceus135 |
Cytotoxic activity (IC50, 21 μg/mL against HeLa cell line)35 |
|
A. amoenus172 Aspergillus sp.136 |
|
|
A. protuberus 62 | |
|
Aspergillus sp.37,176 | |
|
A. amoenus 172 | |
|
Aspergillus sp.37 | |
|
Aspergillus sp.39,136,174 A. ostianus135 |
Anti-inflammatory activity (IC50, 34.3 μM against P. acnes-induced THP-1 cells)136 |
|
A. amoenus 172 | |
|
Aspergillus sp 136 | |
|
A. ochraceus 135 | |
|
A. sulphureus and I. felina co-culture 132 | |
|
Chemical synthesis61 | |
|
Chemical synthesis61 | |
|
Chemical synthesis61 | Inhibition of RANKL-induced osteoclastogenic differentiation (IC50, 1.7 μM against murine RAW264 cells)133 |
|
Chemical synthesis61 | Inhibition of RANKL-induced osteoclastogenic differentiation (IC50, 4.4 μM against murine RAW264 cells)133 |
|
A. protuberus 61 | |
|
A. protuberus 62 | |
|
A. protuberus 62 | |
|
A. protuberus 62 | |
|
A. protuberus 62 | |
|
A. protuberus 62 | |
|
A. protuberus 62 | |
|
A. protuberus 62 | |
|
A. protuberus 62 | |
|
Aspergillus sp.39 | |
|
A. taichungensis 64 | |
|
A. amoenus 172 | |
|
A. taichungensis 64 | |
|
A. ochraceus 135 | |
|
Photoinduced product175 | |
|
A. ochraceus 135 | |
|
A. ochraceus 135 | |
|
A. ochraceus135 Aspergillus sp.136 |
|
|
A. taichungensis64 A. amoenus36 Aspergillus sp.137 A. ochraceus138 |
Inhibition of RANKL-induced osteoclastogenic differentiation133 Antibacterial activity (MIC, 14.5 μM against S. epidermidis)137 Mitochondrial respiratory inhibitor (IC50, 34.6 μM against NADH oxidase)138 |
|
A. ochraceus43,131,135,177 Aspergillus sp.174,176 A. tennesseensis178 A. versicolor66,135 A. cf. stygium171 A. protuberus34 |
Cytotoxic activity (IC50, 1.0–13.1 μM against various human tumor cell lines)43 Anti-inflammatory activity (46.5% and 32.6% inhibition ratios of cytokines IL-1β and TNF-α at the concentration of 20 μM, respectively)131 |
|
A. amoenus 60 | |
|
A. taichungensis64,115 Aspergillus sp.62 A. amoenus60 |
Inhibition of RANKL-induced osteoclastogenic differentiation133 |
|
A. taichungensis 175 | |
|
A. ochraceus
43,179
A. westerdijkiae 180 |
Cytotoxic activity (IC50, 0.06–0.46 μM against various human tumor cell lines; GI50, 135, 346, 91, and 289 nM against LNCap, βT-549, T-47D, and MALME-3M cell lines, respectively)43,181 Antitumor activity (IC50, 0.091, 0.194, 0.403, and 0.268 μM against SMMC-7721, HCT-8, MCF-7, and HUVEC cell lines; IC50, 0.42–3.19 μM against various liver cancer cell lines) 135 |
|
Chemical synthesis182 | |
|
Aspergillus sp.37 A. versicolor135 |
|
|
A. taichungensis64 A. amoenus36 Aspergillus sp.37,62 A. versicolor62,63,135 |
|
|
A. taichungensis 64 | |
|
A. taichungensis 64 | |
|
A. taichungensis 64 | |
|
A. taichungensis 64 | |
|
A. ochraceus
131
A. taichungensis 64 |
Anti-inflammatory activity (38.9% and 34.5% inhibition ratios of cytokines IL-1β and TNF-α at the concentration of 20 μM, respectively)131 |
|
A. versicolor 66 | |
|
A. taichungensis
64
A. cf. stygium 171 |
|
|
A. taichungensis 64 | |
|
A. taichungensis 64 | |
|
A. versicolor
65
F. sambucinum 134 A. ochraceus 65,139 |
Antimicrobial activity (MIC, 4–32 μg/mL against multiple bacteria and fungi; MIC of 0.8 μM against P. aeruginosa)134,139 |
|
Aspergillus sp.174 | Anti-biofilm formation activity (IC50, 1.4 μM against Candida albicans)114 |
|
Aspergillus sp.174 | |
|
Aspergillus sp.170 | Antiproliferative activity (IC50, 0.519, 1.855, 0.62, and 0.78 μM against HT1080, PC3, Jurkat, and A2780S cell lines, respectively)170 |
|
Aspergillus sp.170 | |
|
Aspergillus sp.170 | Antiproliferative activity (IC50, 1.135, 1.805, 1.79 and 1.127 μM against HT1080, PC3, Jurkat, and A2780S cell lines, respectively)170 |
|
F. sambucinum134 Aspergillus sp.136,174 A. sclerotiorum183 A. ochraceus131,173,177 A. protuberus34 A. sulphureus and I. felina co-culture132 |
Insecticidal activity (83.2% mortality rate under diet at 500 ppm against Helicoverpa armigera; 46% mortality rate under diet at 200 ppm against Helicoverpa zea)134,183 Antimicrobial activity (MIC, 4–16 μg/mL against multiple bacteria and fungi; MIC of 25 μg/mL against R. solani)134,136 Anti-inflammatory activity (IC50, 41.6 μM against P. acnes-induced THP-1 cells)136 Caseinolytic protease P (ClpP) activator (EC50, 39.6, 87.5, and 2.6 μM for decapeptide (DFAP), FITC-casein, and Hill slope, respectively) 184 Anticancer activity (~65% inhibition ratio of the colony formation of 22Rv1 prostate cancer cells at 100 μM)132 |
|
A. amoenus 55 | |
|
A. westerdijkiae 185 | |
|
A. sulphureus and I. felina co-culture 132 | |
|
A. sulphureus and I. felina co-culture 132 | |
|
A. westerdijkiae 185,186 | |
|
F. sambucinum 134 | Insecticidal activity (70.2% mortality rate under diet at 500 ppm against H. armigera)134 Antimicrobial activity (MIC, 8–32 μg/mL against multiple bacteria and fungi)134 |
|
A. sclerotiorum 187 | Cytotoxic activity (IC50, 1.7, 1.6, 1.8, and 1.5 μM against HeLa, A549, HepG2, and SMMC-7721 cell lines, respectively)187 |
|
A. sclerotiorum 187 | Cytotoxic activity (IC50 >10 μM against HeLa, A549, HepG2, and SMMC-7721 cell lines)187 |
|
A. sclerotiorum 187 | Cytotoxic activity (IC50 >10 μM against HeLa, A549, HepG2, and SMMC-7721 cell lines)187 |
|
A. sclerotiorum 187 | Cytotoxic activity (IC50, 7.9, 7.8, 8.1, and 6.7 μM against HeLa, A549, HepG2, and SMMC-7721 cell lines, respectively)187 |
|
A. sclerotiorum 187 | Cytotoxic activity (IC50 >10 μM against HeLa, A549, HepG2, and SMMC-7721 cell lines)187 |
|
A. sclerotiorum 187 | Cytotoxic activity (IC50 >10 μM against HeLa, A549, HepG2, and SMMC-7721 cell lines)187 |
|
A. amoenus 188 | |
|
F. sambucinum 134 | Antimicrobial activity (MIC, 1–32 μg/mL against multiple bacteria and fungi)134 |
|
A. ochraceus135,189,190 Aspergillus sp.174,191 A. westerdijkiae180 |
Antitumor activity (IC50, 0.059, 0.209, 2.443, and 1.225 μM against SMMC-7721, HCT-8, MCF-7, and HUVEC cell lines, respectively; IC50, 0.63–3.39 μM against various liver cancer cell lines; IC50, 1100, 643, 116, 112 and 78 nM against NB4, HL-60, MV4-11, OCI-AML3, and Molm-13 acute myeloid leukemia (AML) cell lines, respectively; GI50 (growth-inhibitory potencies), 0.33 and 0.42 μM against T-47D and LNCap cell lines, respectively; IC90, 1.1 μg/mL against HeLa cell line; GI50, 0.24, 0.62, 0.20, and 0.41 μM against LNCap, βT-549, T-47D, and MALME-3M cell lines, respectively)135,181,189,190,192 Antibacterial activity (MIC, 12.5, 12.5, and 25 μg/mL against Staphylococcus aureus, Streptococcus pyogenes, and Enterococcus faecalis, respectively)190 |
|
A. taichungensis 64,175 | |
|
Chemical synthesis182 | |
|
A. ochraceus 115,193 | |
|
A. ochraceus 115,193 | |
|
Aspergillus sp.136 | Antimicrobial activity (MIC, 8–100 μg/mL against multiple bacteria and fungi) 136 Anti-inflammatory activity (IC50, 30.5 μM against P. acnes-induced THP-1 cells)136 |
|
Aspergillus sp.136 | |
|
Aspergillus sp.136 | |
|
Aspergillus sp.136 | Antifungal activity (MIC, 25 μg/mL against R. solani)136 Anti-inflammatory activity (IC50, 30.5 μM against P. acnes-induced THP-1 cells)136 |
|
A. versicolor 194 | |
|
A. versicolor 194 | |
|
A. versicolor 194 | |
|
A. versicolor 194 | |
|
A. versicolor 194 | |
|
Paecilomyces variotii 194,195 | Cytotoxic activity (IC50, 55.9 μM against NCI-H460 cell line)195 |
|
A. tennesseensis 178 | Antiproliferative activity (IC50, 83.4 μM against H460 cell)178 |
|
A. tennesseensis 178 | Antiproliferative activity (IC50, 95.5 μM against H460 cell)178 |
|
A. tennesseensis 178 | |
|
Aspergillus sp. TE-65L196 | Anti-inflammatory activity196 |
|
A. taichungensis 299197 | Cytotoxic activity (IC50, 19.2, 23.4, 48.5, and 1.7 μM against A549, HeLa, HepG2, and AGS cell lines, respectively)197 |
| Monoketopiperazines | ||
|
P. purpurogenum
198
Malbranchea graminicola 69 M. aurantiaca 142 |
Calmodulin inhibitory activity (IC50, 35.73 μM)142 |
|
P. purpurogenum
198
M. aurantiaca 142 |
|
|
M. circinate
143
M. aurantiaca 67,68,142,144 M. graminicola 69 |
Calmodulin inhibitory activity (IC50, 3.65 μM67,141; IC50, 19.33 μM140) Vasorelaxant activity (EC50, 2.7 μM)144 α-Glucosidase (αGHY) inhibitory activity (IC50, 71.3 and 458.7 μM for yeast and rat, respectively)143 Protein Tyrosine Phosphatase 1B (PTP-1B) inhibitory activity (IC50, 14.5 μM)143 Inhibition of radicle growth of Amaranthus hypochondriacus (IC50, 0.37 μM)67 |
|
M. aurantiaca
68,142,144
M. graminicola 69 |
Calmodulin inhibitory activity (IC50, 183.28 μM)142 Vasorelaxant activity (EC50, 33.3 μM)144 |
|
M. graminicola
69
M. aurantiaca 142,144 |
Calmodulin inhibitory activity (IC50, 41.56 μM)142 Vasorelaxant activity (EC50, 25.5 μM)144 |
|
M. graminicola 69 | |
|
M. graminicola 69 | |
|
Enzymatic product93 | |
|
Enzymatic product93 | |
|
Enzymatic product199 | |
|
||
|
M. graminicola 69,80 | |
|
Enzymatic product80 | |
|
Enzymatic product80 | |
|
Enzymatic product80 | |
|
Enzymatic product80 | |
|
P. herquei
200
P. fellutanum 76 A. japonicus A. aculeatinus 79 |
|
|
Aspergillus sp.81 P. janthinellum78 Penicillium spp.72 P. fellutanum76 A. japonicus76 Penicillium sp.73 P. cluniae77 P. charlesii74 |
Anthelmintic activity (100% reduction in faecal egg count with dose at 2.0 mg/kg; MIC50 of 31.2 μg/ml in vitro; 98% effective against T. colubriformis infection at an oral dose of 1.56 mg/kg)72,73,146,201 Insecticidal activity (LD50, 2.5 μg/ml against Caenorhabditis elegans; LD50 of 0.32 μg/nymph against O. fasciatus)74,77 |
|
P. charlesii
74
P. cluniae 77 |
Insecticidal Activity (LD50, 100 μg/ml against C. elegans; LD50, 16.54 μg/nymph against O. fasciatus)74,77 |
|
P. charlesii 74 | Insecticidal Activity (LD50, 40 μg/ml against C. elegans)74 |
|
P. charlesii 74 | Insecticidal Activity (LD50, 160 μg/ml against C. elegans)74 |
|
Aspergillus sp.81 A. aculeatinus79 A. aculeatus202 P. janthinellum78 P. charlesii74 P. cluniae77 |
Anthelmintic activity (88, 96, and 99% reductions in faecal egg counts with dose at a dose of 0.5, 1.0, and 2.0 mg/kg against adult T. colubriformis infection, respectively)81 Cytotoxic activity (IC50, 1.9 μM against Bel-7402 cell line)79 Insecticidal activity (LD50, 6 μg/ml against C. elegans; LD50 0.089 μg/nymph against O. fasciatus)74,77 |
|
Penicillium sp.73 P. charlesii74 |
Insecticidal Activity (LD50, 65 μg/ml against C. elegans)74 Anthelmintic activity (MIC50 >500 μg/ml in vitro)73 |
|
Penicillium sp.73 P. charlesii74 |
Insecticidal activity (LD50, 20 μg/ml against C. elegans)74 Anthelmintic activity (MIC50 >500 μg/ml in vitro)73 |
|
P. cluniae 77 | |
|
P. cluniae 77 | |
|
P. janthinellum 78 | |
|
A. aculeatinus79 P. simplicissimum ΔphqK80 |
|
|
P. janthinellum 78 | |
|
P. simplicissimum ΔphqK80 | |
|
A. aculeatinus79 Penicillium spp.72 Enzymatic product80 |
|
|
Aspergillus sp.81 A. aculeatinus79 P. janthinellum78 Enzymatic product80 |
|
|
Penicillium spp. 72 P. cluniae77 |
Anthelmintic activity (94% reduction in faecal egg count with dose at 2.0 mg/kg)72 Insecticidal activity (LD50, 7.01 μg/nymph against O. fasciatus)77 |
|
Penicillium spp.72 P. cluniae77 |
Insecticidal activity (LD50, 0.91 μg/nymph against O. fasciatus)77 |
|
P. fellutanum76 Penicillium spp.72,88 |
|
|
Aspergillus sp.73,81 | Anthelmintic activity (MIC50, 15.6 μg/ml in vitro)73 |
|
A. aculeatinus 79 | Cytotoxic activity (IC50, 3.3 μM against Bel-7402 cell line)79 |
|
P. herquei 200 | |
|
P. herquei 200 | Anti-HCV activity (IC50, 5.1 μM)200 |
|
Aspergillus sp.81 A. japonicus203,204 |
Paralytic activity (against silkworms at a dose of 10 μg/g of diet and 3 μg/g of body weight with injection method)203,204 |
|
Aspergillus sp.81 | Anthelmintic Activity (in vitro)81 |
|
A. japonicus 204 | Paralytic activity (against silkworms at a dose of 10 μg/g of diet and 3 μg/g of body weight with injection method)204 |
|
A. japonicus 204 | Paralytic activity (against silkworms at a dose of 10 μg/g of diet and 3 μg/g of body weight with injection method)204 |
|
P. citrinum 205 | |
|
Penicillium sp.206 | Protein tyrosine phosphatase 1B (PTP-1B) inhibitory activity (IC50, 27.6 μM)206 |
|
P. purpurogenum 198 | |
|
P. purpurogenum 198 | |
|
P. oxalicum 207 | Brine shrimp (A. salina) lethality (LD50, 5.6 μM)207 |
|
P. oxalicum 208 | Cytotoxic activity (IC50, 28.12 μM against HL-60 cell line)208 |
|
P. paneum
209,210
P. roqueforti 211–213 A. carneus 214 |
Cytotoxic activity210 |
|
P. paneum
209,210
P. roqueforti 211–213 |
Cytotoxic activity210 |
|
P. paneum
210
P. roqueforti 211–213 |
Cytotoxic activity210 |
|
P. chrysogenum
215
P. citrinum 216 |
Neurocyte protection activity (improving cells viability by 59.6% at the concentration of 1 × 10−4 mM)215 Antifungal activity (reduced 61% of P. digitatum radial growth at 400 μg/mL)216 |
|
Penicillium sp.217,218 P. herquei200 |
|
|
Penicillium sp.217 | |
|
Penicillium sp.217,218 P. herquei200 |
Anti-acetylcholinesterase activity (IC50, 58.0 μM)217 |
|
Penicillium sp.218 | |
|
Penicillium sp.218 | |
|
Penicillium sp.218 | |
|
Penicillium sp.218 | |
|
A. duricaulis 219 | |
|
A. duricaulis 219 | |
|
A. duricaulis 219 | Inhibitory effect on Aβ aggregation (IC50, 269.5 μM)219 |
|
A. duricaulis 219 | |
|
A. duricaulis 219 | Inhibitory effect on Aβ aggregation (IC50, 244.3 μM)219 |
|
A. duricaulis 219 | |
|
A. duricaulis 219 | Protecting cells against beta-amyloid (Aβ) aggregate-induced toxicity (EC50, 149.6 μM), and inhibiting Aβ aggregation (IC50, 186.6 μM)219 |
|
P. citrinum 4,97 | |
|
P. citrinum 97 | |
|
P. citrinum 4 | |
|
P. citrinum 4 | |
|
P. citrinum 97 |
IC50: half maximal inhibitory concentration. EC50: half maximal effective concentration. LD50: half of the lethal dose. MIC: minimum inhibitory concentration.